The Research and Development Team at Azura Ophthalmics is dedicated to advancing innovative treatments for Meibomian gland dysfunction and Dry Eye Disease. Comprising experts in scientific research, medical oversight, formulation, and regulatory compliance, the team collaborates to develop and optimize novel compounds, conduct clinical trials, and ensure the effective translation of research findings into safe and effective therapies for patients. Their work aims to address unmet medical needs in ocular health and improve the quality of life for individuals affected by these conditions.
View all